[1]
Bai, R. et al. 2020. Pathological response rate in patients who achieve clinical response after neoadjuvant concurrent chemoradiotherapy in localized esophageal cancer. Journal of Fatima Jinnah Medical University. 14, 03 (Dec. 2020), 114–118. DOI:https://doi.org/10.37018/qsqy1921.